Genmab
Tommy Li, PhD, is a Director in the Department of Clinical Pharmacology and Quantitative Science at Genmab. He received his Doctor of Philosophy degree in pharmaceutical science from the University at Buffalo. His interests are antibody PK/PD, antibody PBPK modeling, monoclonal antibody and bispecific antibody drug development in immune-oncology, pharmacometrics, and QSP modeling. His work has been published in peer-reviewed journals such as The Lancet, Blood, Clinical Pharmacology & Therapeutics, and Journal of Pharmaceutical Sciences.